HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Kaneko Selected Research

nemonapride

8/2000Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactin.
6/2000No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study.
4/2000Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Kaneko Research Topics

Disease

15Hepatocellular Carcinoma (Hepatoma)
01/2017 - 01/2000
14Neoplasms (Cancer)
05/2012 - 01/2000
6Body Weight (Weight, Body)
12/2012 - 03/2000
5Infections
10/2017 - 07/2000
5Schizophrenia (Dementia Praecox)
07/2010 - 06/2000
4Seizures (Absence Seizure)
04/2018 - 01/2000
4Epilepsy (Aura)
10/2009 - 01/2000
4Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
07/2006 - 02/2000
4Chronic Hepatitis C
10/2001 - 01/2000
3Parkinson Disease (Parkinson's Disease)
09/2013 - 08/2002
3Type 2 Diabetes Mellitus (MODY)
02/2009 - 04/2004
3Neoplasm Metastasis (Metastasis)
06/2005 - 01/2001
3Carcinogenesis
10/2001 - 01/2001
3Renal Cell Carcinoma (Grawitz Tumor)
10/2001 - 01/2001
2Congenital Abnormalities (Deformity)
12/2016 - 01/2000
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2016 - 01/2000
2Chronic Hepatitis B
12/2015 - 03/2001
2Pathologic Constriction (Stenosis)
12/2014 - 09/2001
2Fibrosis (Cirrhosis)
02/2011 - 08/2007
2Necrosis
02/2011 - 05/2001
2Pain (Aches)
06/2008 - 06/2007
2Hyperalgesia
06/2008 - 06/2007
2Febrile Seizures (Febrile Seizure)
08/2006 - 01/2002
2Generalized Epilepsy with Febrile Seizures Plus
07/2004 - 08/2001
2Lymphatic Metastasis
12/2001 - 01/2001
2Chronic Periodontitis
10/2001 - 05/2001
2Autoimmune Hepatitis
06/2001 - 01/2001
2Hepatitis
06/2001 - 03/2001
2Hyperprolactinemia
04/2001 - 04/2000
2Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions)
11/2000 - 06/2000
1Growth Disorders
08/2019
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
10/2018
1Hypersensitivity (Allergy)
05/2018
1Dizziness (Lightheadedness)
04/2018
1Experimental Arthritis
01/2017
1Allergic Rhinitis
01/2016
1Hepatitis B
12/2015
1Pemphigus (Pemphigus Vulgaris)
07/2015
1Thymoma (Thymic Carcinoma)
07/2015
1Hyperbilirubinemia
12/2014
1Thrombocytopenia (Thrombopenia)
12/2014
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
12/2014

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
08/2019 - 01/2000
7alpha-Fetoproteins (alpha-Fetoprotein)IBA
06/2005 - 01/2001
5CytokinesIBA
10/2013 - 01/2000
5Complementary DNA (cDNA)IBA
06/2005 - 03/2001
4DNA (Deoxyribonucleic Acid)IBA
02/2013 - 07/2000
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2012 - 10/2001
4Ganciclovir (Cytovene)FDA LinkGeneric
04/2006 - 01/2001
4Thymidine KinaseIBA
04/2006 - 01/2001
4Anticonvulsants (Antiepileptic Drugs)IBA
07/2004 - 01/2000
4Pharmaceutical PreparationsIBA
01/2001 - 01/2000
3AcidsIBA
04/2018 - 01/2000
3Sorafenib (BAY 43-9006)FDA Link
01/2017 - 10/2013
3InterferonsIBA
01/2017 - 07/2001
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2013 - 12/2001
3Messenger RNA (mRNA)IBA
05/2012 - 08/2001
3Immunoglobulin G (IgG)IBA
10/2001 - 02/2001
3ProlactinIBA
04/2001 - 04/2000
3nemonaprideIBA
08/2000 - 04/2000
2Immunoglobulin E (IgE)IBA
05/2018 - 04/2005
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 11/2016
2Peptides (Polypeptides)IBA
12/2015 - 04/2005
2LeptinIBA
10/2013 - 09/2006
2AntibodiesIBA
03/2012 - 08/2007
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2012 - 04/2005
2InterleukinsIBA
02/2011 - 06/2000
2Amino AcidsFDA Link
10/2009 - 05/2001
2Glucose (Dextrose)FDA LinkGeneric
02/2007 - 04/2004
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
06/2005 - 12/2001
2Voltage-Gated Sodium ChannelsIBA
07/2004 - 08/2001
2Fc Receptors (Fc Receptor)IBA
06/2004 - 10/2001
2Immunoglobulin A (IgA)IBA
06/2004 - 05/2001
2Dopamine (Intropin)FDA LinkGeneric
10/2001 - 06/2000
2Adrenal Cortex Hormones (Corticosteroids)IBA
09/2001 - 03/2000
2RNA (Ribonucleic Acid)IBA
07/2001 - 07/2000
2Antipsychotic Agents (Antipsychotics)IBA
04/2001 - 04/2000
2bromperidol (Impromen)IBA
04/2001 - 06/2000
1perampanelIBA
04/2018
1AMPA Receptors (AMPA Receptor)IBA
04/2018
1DaptomycinFDA Link
10/2017
1Teriparatide (Parathar)FDA Link
12/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1indium-bleomycinIBA
01/2016
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2015
1HLA-DPB1 antigen (HLA DPB1)IBA
12/2015
1HLA-DP Antigens (HLA-DP)IBA
12/2015
1AntigensIBA
12/2015
1Desmoglein 1IBA
07/2015
1Glycoproteins (Glycoprotein)IBA
12/2014
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2013
1FollistatinIBA
10/2013

Therapy/Procedure

13Therapeutics
12/2016 - 01/2000
4Drug Therapy (Chemotherapy)
01/2017 - 01/2001
2Immunotherapy
01/2016 - 10/2001
2Transplantation
04/2005 - 04/2001
2Aftercare (After-Treatment)
01/2001 - 06/2000
2Nephrectomy
01/2001 - 01/2000
1Liver Transplantation
12/2014
1Heterologous Transplantation (Xenotransplantation)
12/2014